Aims Limited data compared antiarrhythmic drugs (AADs) with concomitant non-vitamin K
antagonist oral anticoagulants in atrial fibrillation patients, hence the aim of the study …

Objective: Mixed treatment comparison (MTC) is increasingly used to estimate the treatment
effects when directly randomised comparisons are not available. MTCs make the best use of …

We aimed to evaluate the effectiveness and safety of dronedarone versus sotalol in real-
world practice in Asian patients with atrial fibrillation (AF). Using the Korean nationwide …

The antiarrhythmic drug dronedarone was designed to reduce the extra-cardiac adverse
effects associated with amiodarone use in treatment of patients with atrial fibrillation/atrial …

Aims To evaluate the effectiveness and safety of dronedarone compared with other
commonly used antiarrhythmic drugs (AADs) for preventing atrial fibrillation (AF) …

BACKGROUND: Sotalol and dronedarone are both used for maintenance of sinus rhythm for
patients with atrial fibrillation. However, while sotalol requires initial monitoring for QT …

No published studies have evaluated the risks of cardiovascular (CV) events, stroke,
congestive heart failure (CHF), interstitial lung disease (ILD), and severe acute liver injury …

Methods Four retrospective observational cohort analyses were conducted using an as-
treated approach and propensity score matching (PSM) for confounding control. Each cohort …

Efficacy and safety of dronedarone was shown in the ATHENA trial for paroxysmal or
persistent atrial fibrillation (AF) patients. Further trials revealed safety concerns in patients …

Aims Age and sex may impact the efficacy of antiarrhythmic drugs on cardiovascular
outcomes and arrhythmia recurrences in patients with atrial fibrillation (AF). We report on a …